Clinical Trial Update: New Clinical Outcome Measures to Remotely Evaluate Patients With FacioScapuloHumeral Muscular Dystrophy [NA]

View source ↗

Summary

This update describes the development of new remote clinical outcome measures for evaluating patients with facioscapulohumeral muscular dystrophy (FSHD), Type 1…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Facioscapulohumeral Muscular Dystrophy

Snippet

Sponsor: Centre Hospitalier Universitaire de Nice | Conditions: Type 1 Facioscapulohumeral Muscular Dystrophy | NA | Status: COMPLETED